Lisa Wisniewski
InvestorChief Scientific Officer at Global BioAccess Fund
New York City Metropolitan Area
About
Lisa Wisniewski is Chief Scientific Officer at Global BioAccess Fund and a drug development executive with over 25 years of experience across therapeutic areas including oncology, anti-infectives, and vaccines. A licensed investment banker and Managing Director at RM Global Partners, she advises clients on asset development, private placements, and out-licensing, and she serves as CSO for the RMG Healthcare Fund. Her prior roles include Vice President of R&D Operations at Ikaria and Executive Director, Global Program Leader at Celgene, along with earlier positions at Novartis and Chiron.
ContactΒ· self-published, not guessed
Invests in
Biotech
Experience
- Global BioAccess FundManaging Directorcurrent2021 β presentNew York City, NY
- RM Global PartnersManaging Directorcurrent2016 β presentNew York City Metropolitan Area
- S3B Consulting, LLCPresidentcurrent2014 β presentNew York City Metropolitan Area
- Mount Sinai Innovation PartnersExecutive in Residence2015 β 2025New York City Metropolitan Area
- EcoHealth AllianceBoard Member2020 β 2023New York, New York, United States
- IKARIA, Inc.Vice President, R&D Operations2012 β 2014New York City Metropolitan Area
- CelgeneExecutive Director, Project Leader2008 β 2012New York City Metropolitan Area
- Novartis OncologyGlobal Project Leader2006 β 2008New York City Metropolitan Area
- Chiron CorporationSr Director, Project Leader1999 β 2006Emeryville, CA
- PPDSenior Project Manager1999
- Shaman PharmaceuticalsProject Manager1996 β 1999South San Francisco, CA
- Glyko, IncTechnical Specialist and Sales Representative1995 β 1996Novato, CA
- Axis GeneticsProject Leader1991 β 1995Cambridge, United Kingdom
Skills & more
+12 more
FDACRORegulatory SubmissionsVaccinesLeadershipProduct LaunchMedical WritingProject ManagementINDClinical ResearchRegulatory AffairsClinical Data ManagementLanguages Italian Β· Japanese
From Lisa's professional profile.
Colleagues at Global BioAccess Fund
Frequently asked questions
- Who is Lisa Wisniewski?
- Lisa Wisniewski is Chief Scientific Officer at Global BioAccess Fund and a drug development executive with over 25 years of experience across therapeutic areas including oncology, anti-infectives, and vaccines. A licensed investment banker and Managing Director at RM Global Partners, she advises clients on asset development, private placements, and out-licensing, and she serves as CSO for the RMG Healthcare Fund. Her prior roles include Vice President of R&D Operations at Ikaria and Executive Director, Global Program Leader at Celgene, along with earlier positions at Novartis and Chiron.
- Where does Lisa Wisniewski work?
- Lisa Wisniewski is Chief Scientific Officer at Global BioAccess Fund.
- What does Lisa Wisniewski invest in?
- Lisa Wisniewski invests in Biotech.
- Where did Lisa Wisniewski go to school?
- Lisa Wisniewski studied at North Carolina State University (PhD); North Carolina State University (Master of Science (MS)); University of Illinois Urbana-Champaign (BS).
Same school
Also attended North Carolina State University111
+ 105 more
Also attended University of Illinois Urbana-Champaign488
+ 482 more
Shared employers
Also worked at S3B Consulting, LLC1
Also worked at Mount Sinai Innovation Partners4
Also worked at IKARIA, Inc.2
Also worked at Novartis Oncology164
+ 158 more



































